5-HT	5-hydroxytryptamine or serotonin
ADAMPA	Alzheimer’s diseaseα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
ASIB	acute suicidal ideation and behavior
BDNF	brain-derived neurotrophic factor
EEG	electroencephalogram
FDA	Food and Drug Administration
GABA	gamma amino butyric acid
GABAAR	GABAA receptor
ICSS	intracranial self-stimulation
LPS	lipopolysaccharide
M-5MPEP	2-(2-(3-methoxyphenyl)ethynyl)-5-methylpyridine
mGlu	metabotropic glutamate
mPFC	medial prefrontal cortex
mTOR	mammalian target of rapamycin
MS	multiple sclerosis
NMDA	N-methyl-D-aspartate
PBA	pseudobulbar affect
PCP	phencyclidine
PFC	prefrontal cortex
REM	rapid eye movement sleep
nREM	non-rapid eye movement sleep
PD	Parkinson’s disease
PTSD	post-traumatic stress syndrome
SOC	standard of care
SUD	substance abuse disorder
TRD	treatment-resistant depression